MedPath

VYXEOS

VYXEOS

Approved
DIN Number

02515490

Drug Class

Human

Market Date

Jul 6, 2021

Company
HC

JAZZ PHARMACEUTICALS IRELAND LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02515490
AIG Number0262869001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01XY01 CYTARABINE AND DAUNORUBICIN
Product Specifications
Dosage FormPowder
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CYTARABINEActive
Strength: 100 MG
Monograph: CYTARABINE
DAUNORUBICINActive
Strength: 44 MG
Monograph: DAUNORUBICIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.